N-[5-carbamoyl-1-[(E)-4-[6-carbamoyl-2-(4-ethyl-1,3-oxazole-5-carbonyl)imino-4-methoxy-1,3-benzothiazol-3-yl]but-2-enyl]-7-(3-hydroxypropoxy)benzimidazol-2-yl]-4-ethyl-1,3-oxazole-5-carboxamide

C36H37N9O9S — CID 155787022

IUPACN-[5-carbamoyl-1-[(E)-4-[6-carbamoyl-2-(4-ethyl-1,3-oxazole-5-carbonyl)imino-4-methoxy-1,3-benzothiazol-3-yl]but-2-enyl]-7-(3-hydroxypropoxy)benzimidazol-2-yl]-4-ethyl-1,3-oxazole-5-carboxamide
SMILESCCc1ncoc1C(=O)/N=c1\sc2cc(C(N)=O)cc(OC)c2n1C/C=C/Cn1c(NC(=O)c2ocnc2CC)nc2cc(C(N)=O)cc(OCCCO)c21
InChIInChI=1S/C36H37N9O9S/c1-4-21-29(53-17-39-21)33(49)42-35-41-23-13-19(31(37)47)15-25(52-12-8-11-46)27(23)44(35)9-6-7-10-45-28-24(51-3)14-20(32(38)48)16-26(28)55-36(45)43-34(50)30-22(5-2)40-18-54-30/h6-7,13-18,46H,4-5,8-12H2,1-3H3,(H2,37,47)(H2,38,48)(H,41,42,49)/b7-6+,43-36-
InChIKeyACARMKDCHYCTQG-BGPKLBSVSA-N
MW771.81 g/mol
LogP3.37
Rot. Bonds16

About N-[5-carbamoyl-1-[(E)-4-[6-carbamoyl-2-(4-ethyl-1,3-oxazole-5-carbonyl)imino-4-methoxy-1,3-benzothiazol-3-yl]but-2-enyl]-7-(3-hydroxypropoxy)benzimidazol-2-yl]-4-ethyl-1,3-oxazole-5-carboxamide

N-[5-carbamoyl-1-[(E)-4-[6-carbamoyl-2-(4-ethyl-1,3-oxazole-5-carbonyl)imino-4-methoxy-1,3-benzothiazol-3-yl]but-2-enyl]-7-(3-hydroxypropoxy)benzimidazol-2-yl]-4-ethyl-1,3-oxazole-5-carboxamide (PubChem CID 155787022) has the molecular formula C36H37N9O9S and a molecular weight of 771.81 g/mol. Its IUPAC name is N-[5-carbamoyl-1-[(E)-4-[6-carbamoyl-2-(4-ethyl-1,3-oxazole-5-carbonyl)imino-4-methoxy-1,3-benzothiazol-3-yl]but-2-enyl]-7-(3-hydroxypropoxy)benzimidazol-2-yl]-4-ethyl-1,3-oxazole-5-carboxamide.

Molecular Properties

Compound NameN-[5-carbamoyl-1-[(E)-4-[6-carbamoyl-2-(4-ethyl-1,3-oxazole-5-carbonyl)imino-4-methoxy-1,3-benzothiazol-3-yl]but-2-enyl]-7-(3-hydroxypropoxy)benzimidazol-2-yl]-4-ethyl-1,3-oxazole-5-carboxamide
PubChem CID155787022
Molecular FormulaC36H37N9O9S
Molecular Weight771.81 g/mol
Exact Mass771.24
IUPAC NameN-[5-carbamoyl-1-[(E)-4-[6-carbamoyl-2-(4-ethyl-1,3-oxazole-5-carbonyl)imino-4-methoxy-1,3-benzothiazol-3-yl]but-2-enyl]-7-(3-hydroxypropoxy)benzimidazol-2-yl]-4-ethyl-1,3-oxazole-5-carboxamide
SMILESCCc1ncoc1C(=O)/N=c1\sc2cc(C(N)=O)cc(OC)c2n1C/C=C/Cn1c(NC(=O)c2ocnc2CC)nc2cc(C(N)=O)cc(OCCCO)c21
InChIInChI=1S/C36H37N9O9S/c1-4-21-29(53-17-39-21)33(49)42-35-41-23-13-19(31(37)47)15-25(52-12-8-11-46)27(23)44(35)9-6-7-10-45-28-24(51-3)14-20(32(38)48)16-26(28)55-36(45)43-34(50)30-22(5-2)40-18-54-30/h6-7,13-18,46H,4-5,8-12H2,1-3H3,(H2,37,47)(H2,38,48)(H,41,42,49)/b7-6+,43-36-
InChIKeyACARMKDCHYCTQG-BGPKLBSVSA-N
XLogP3.37
TPSA258.21 Ų
H-Bond Donors4
H-Bond Acceptors15
Rotatable Bonds16
Heavy Atoms55
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500771.81
LogP ≤ 53.37
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1015

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'isolated_alkene', 'substructure': 'N/A'}

Analyze N-[5-carbamoyl-1-[(E)-4-[6-carbamoyl-2-(4-ethyl-1,3-oxazole-5-carbonyl)imino-4-methoxy-1,3-benzothiazol-3-yl]but-2-enyl]-7-(3-hydroxypropoxy)benzimidazol-2-yl]-4-ethyl-1,3-oxazole-5-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N-[5-carbamoyl-1-[(E)-4-[6-carbamoyl-2-(4-ethyl-1,3-oxazole-5-carbonyl)imino-4-methoxy-1,3-benzothiazol-3-yl]but-2-enyl]-7-(3-hydroxypropoxy)benzimidazol-2-yl]-4-ethyl-1,3-oxazole-5-carboxamide?
The IUPAC name of N-[5-carbamoyl-1-[(E)-4-[6-carbamoyl-2-(4-ethyl-1,3-oxazole-5-carbonyl)imino-4-methoxy-1,3-benzothiazol-3-yl]but-2-enyl]-7-(3-hydroxypropoxy)benzimidazol-2-yl]-4-ethyl-1,3-oxazole-5-carboxamide (CID 155787022) is N-[5-carbamoyl-1-[(E)-4-[6-carbamoyl-2-(4-ethyl-1,3-oxazole-5-carbonyl)imino-4-methoxy-1,3-benzothiazol-3-yl]but-2-enyl]-7-(3-hydroxypropoxy)benzimidazol-2-yl]-4-ethyl-1,3-oxazole-5-carboxamide.
What is the SMILES notation for N-[5-carbamoyl-1-[(E)-4-[6-carbamoyl-2-(4-ethyl-1,3-oxazole-5-carbonyl)imino-4-methoxy-1,3-benzothiazol-3-yl]but-2-enyl]-7-(3-hydroxypropoxy)benzimidazol-2-yl]-4-ethyl-1,3-oxazole-5-carboxamide?
The canonical SMILES for N-[5-carbamoyl-1-[(E)-4-[6-carbamoyl-2-(4-ethyl-1,3-oxazole-5-carbonyl)imino-4-methoxy-1,3-benzothiazol-3-yl]but-2-enyl]-7-(3-hydroxypropoxy)benzimidazol-2-yl]-4-ethyl-1,3-oxazole-5-carboxamide is CCc1ncoc1C(=O)/N=c1\sc2cc(C(N)=O)cc(OC)c2n1C/C=C/Cn1c(NC(=O)c2ocnc2CC)nc2cc(C(N)=O)cc(OCCCO)c21.
What is the InChIKey of N-[5-carbamoyl-1-[(E)-4-[6-carbamoyl-2-(4-ethyl-1,3-oxazole-5-carbonyl)imino-4-methoxy-1,3-benzothiazol-3-yl]but-2-enyl]-7-(3-hydroxypropoxy)benzimidazol-2-yl]-4-ethyl-1,3-oxazole-5-carboxamide?
The InChIKey is ACARMKDCHYCTQG-BGPKLBSVSA-N. The full InChI is InChI=1S/C36H37N9O9S/c1-4-21-29(53-17-39-21)33(49)42-35-41-23-13-19(31(37)47)15-25(52-12-8-11-46)27(23)44(35)9-6-7-10-45-28-24(51-3)14-20(32(38)48)16-26(28)55-36(45)43-34(50)30-22(5-2)40-18-54-30/h6-7,13-18,46H,4-5,8-12H2,1-3H3,(H2,37,47)(H2,38,48)(H,41,42,49)/b7-6+,43-36-.
What are the key properties of N-[5-carbamoyl-1-[(E)-4-[6-carbamoyl-2-(4-ethyl-1,3-oxazole-5-carbonyl)imino-4-methoxy-1,3-benzothiazol-3-yl]but-2-enyl]-7-(3-hydroxypropoxy)benzimidazol-2-yl]-4-ethyl-1,3-oxazole-5-carboxamide?
N-[5-carbamoyl-1-[(E)-4-[6-carbamoyl-2-(4-ethyl-1,3-oxazole-5-carbonyl)imino-4-methoxy-1,3-benzothiazol-3-yl]but-2-enyl]-7-(3-hydroxypropoxy)benzimidazol-2-yl]-4-ethyl-1,3-oxazole-5-carboxamide has a molecular weight of 771.81 g/mol, XLogP of 3.37, 16 rotatable bonds, 4 hydrogen bond donors, and 15 hydrogen bond acceptors.
Where does this data come from?
All data for N-[5-carbamoyl-1-[(E)-4-[6-carbamoyl-2-(4-ethyl-1,3-oxazole-5-carbonyl)imino-4-methoxy-1,3-benzothiazol-3-yl]but-2-enyl]-7-(3-hydroxypropoxy)benzimidazol-2-yl]-4-ethyl-1,3-oxazole-5-carboxamide is sourced from PubChem (CID 155787022), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).